Catalent
CTLT
#1737
Rank
HK$89.69 B
Marketcap
HK$494.17
Share price
0.00%
Change (1 day)
13.83%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Cash on Hand

Cash on Hand as of September 2024 : HK$2.60 Billion

According to Catalent's latest financial reports the company has HK$2.60 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalent - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-06-30HK$2.19 B-48.03%
2022-06-30HK$4.22 B-43.77%
2021-06-30HK$7.50 B1.65%
2020-06-30HK$7.38 B173.75%
2019-06-30HK$2.69 B-16.19%
2018-06-30HK$3.21 B34.37%
2017-06-30HK$2.39 B122.77%
2016-06-30HK$1.07 B-8.29%
2015-06-30HK$1.17 B103.38%
2014-06-30HK$0.57 B-30.13%
2013-06-30HK$0.82 B-23.47%
2012-06-30HK$1.07 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Supernus Pharmaceuticals
SUPN
HK$2.18 B-16.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$1.34 B-48.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$15.92 B 510.77%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
HK$2.51 B-3.67%๐Ÿ‡บ๐Ÿ‡ธ USA